Casa
bronstein meier ii

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1

Por um escritor misterioso

Descrição
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Venetoclax resistance: mechanistic insights and future strategies
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Targeting of epigenetic co-dependencies enhances anti-AML efficacy
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Causal linkage of presence of mutant NPM1 to efficacy of novel
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Promising molecules for therapeutic targeting of mutant NPM1 in
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
American Journal of Hematology, Blood Research Journal
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Cancers, Free Full-Text
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
A Box of Chemistry to Inhibit the MEN1 Tumor Suppressor Gene
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
NPM1-mutated acute myeloid leukemia: from bench to bedside
de por adulto (o preço varia de acordo com o tamanho do grupo)